Evidence map›Paper›PMID 35692508›Full record

ArticleJournal of ambient intelligence and humanized computing2022

An equitable and accessible vaccine supply chain network in the epidemic outbreak of COVID-19 under uncertainty.

Mahdyeh Shiri, Fardin Ahmadizar

Open access · bronzeAbstract read
In one paragraph

Article in Journal of ambient intelligence and humanized computing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mahdyeh ShiriDepartment of Industrial Engineering, University of Kurdistan, Sanandaj, Iran.
Fardin AhmadizarDepartment of Industrial Engineering, University of Kurdistan, Sanandaj, Iran.
University of Kurdistan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is one of the most efficient ways to restrict and control the spread of epidemic outbreaks such as COVID-19. Due to the limited COVID-19 vaccine supply, an equitable and accessible plan should be prepared to cope with. This research focuses on designing a vaccine supply chain while aiming to achieve an equitable and accessible network. We present a novel mathematical formulation that helps to optimize vaccine distribution to inoculate people with various priority levels to achieve an equitable plan. The transshipment strategy is also incorporated into the model to enhance the accessibility of COVID-19 vaccine types between health facilities. The nature of COVID-19 is dynamic over time due to mutations, and the protection level of each vaccine type against this disease is not exact. Besides, complete information about the demand for different vaccine types is not available. Hence, we use Multi-Stage Stochastic Programming as a reliable strategy that is organized to manage stochastic data in a dynamic environment for the first time in the vaccine supply chain network. The scenarios in this approach are generated using a Monte Carlo simulation method, and then a forward scenario reduction technique is conducted to construct a suitable scenario tree. The practicality and capability of the model are shown in a real-life case of Iran. The results show that the performance of the Multi-Stage Stochastic Programming is significantly improved compared with the two-stage stochastic programming regarding the total cost of the vaccine supply chain and the number of the shortage units.

Indexed as

COVID-19EquityPriorityTransshipment policyUncertaintyVaccine supply chain

Identifiers

PMID35692508
PMCPMC9171116
OpenAlexW4281861436

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.